Discount sale is live
Discount sale is live

Long Term Care Pharmacy Market Size and Share Analysis - Growth Trends and Forecasts (2025-2032)

Market Size and Trends

The Long Term Care Pharmacy market is estimated to be valued at USD 33.0 billion in 2024 and is expected to reach USD 58.9 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.6% from 2024 to 2032. This significant growth trajectory highlights the increasing demand for medication management and pharmaceutical services tailored to the elderly and chronically ill population. Increasing longevity and a rising prevalence of chronic diseases are key factors propelling the market expansion over the forecast period.

Market trends indicate a robust shift towards integrated healthcare models that incorporate advanced technologies such as telepharmacy and automated dispensing systems within long term care settings. Additionally, there is a growing emphasis on personalized medication management to enhance patient outcomes and reduce adverse drug events. Policy reforms and increased healthcare spending by governments globally also contribute to the rapid adoption of long term care pharmacy services, making it a crucial component of senior healthcare infrastructure.

Segmental Analysis:

By Service Type: Medication Dispensation Leading Growth through Accessibility and Efficiency

In terms of By Service Type, Medication Dispensation contributes the highest share of the Long Term Care Pharmacy market owing to its fundamental role in ensuring the timely delivery of prescribed medications to long-term care patients. This segment's prominence is fueled by the increasing complexity of medication regimens among elderly and chronically ill populations, which necessitates precise and reliable dispensation services. The demand for streamlined medication delivery across nursing homes, assisted living facilities, and home healthcare setups underscores the critical importance of this segment. Furthermore, advancements in automation and packaging technologies have enhanced the accuracy and efficiency of medication dispensation, reducing errors and improving patient outcomes. The growing emphasis on patient safety protocols and regulatory mandates has also reinforced the need for professional dispensation services that can handle complex drug schedules while ensuring compliance. Additionally, the integration of digital health records and prescription management systems reduces administrative burdens, thereby facilitating smoother pharmacy operations that support continuous, personalized medication distribution. Given these factors, the Medication Dispensation segment anchors the entire long-term care pharmacy ecosystem by addressing both clinical and logistical demands in medication management.

By End-User: Nursing Homes Representing the Core Demand Segment

Among end-users, Nursing Homes contribute the highest share of the Long Term Care Pharmacy market driven by the substantial and consistent medication requirements of resident populations. Nursing homes cater to a large demographic of elderly individuals with chronic conditions, multiple comorbidities, and cognitive impairments, all of which require ongoing pharmaceutical care. The comprehensive healthcare environment within these facilities creates a sustained need for a variety of pharmaceutical services, from routine medication administration to intricate therapy management and regulatory oversight. Moreover, nursing homes benefit from coordinated pharmacy services that provide not only medication supply but also clinical insights to optimize treatment plans. This demand is reinforced by increasing life expectancy and the rising prevalence of chronic illnesses, creating a steady patient base with long-term medication needs. The structured nature of nursing homes also facilitates consistent collaboration with long term care pharmacies to manage drug inventories, prevent adverse reactions, and ensure regulatory compliance. These characteristics position nursing homes as a critical segment where pharmacy service quality directly impacts patient safety and quality of care, further driving investment in specialized long-term care pharmacy solutions.

By Drug Type: Oral Solids Dominating Due to Convenience and Versatility

In terms of By Drug Type, Oral Solids hold the largest share within the Long Term Care Pharmacy market, primarily because of their widespread use, ease of administration, and versatility across various therapeutic categories. Oral solids such as tablets and capsules are preferred in long-term care settings for their convenience, cost-effectiveness, and patient acceptability. These formulations allow for precise dosing schedules, which is crucial for elderly patients who often juggle multiple medications. The ability to combine multiple active ingredients into a single tablet also aids in reducing pill burden and enhancing adherence, a significant consideration in long term care populations prone to medication non-compliance. Additionally, oral solids are stable, have longer shelf lives, and are simpler to store and dispense compared to alternative drug forms like injectables or IV medications. This practicality makes them an indispensable component of comprehensive pharmaceutical care in nursing homes, assisted living facilities, and home health care environments. Regulatory bodies and healthcare providers alike encourage the use of oral solids when clinically appropriate, further supporting their dominant position. Innovations in tablet formulations, including controlled-release and orally disintegrating tablets, continue to expand the utility of oral solids in managing complex chronic conditions effectively within the long-term care pharmacy framework.

Regional Insights:

Dominating Region: North America

In North America, the dominance in the Long Term Care Pharmacy market is driven by a well-established healthcare infrastructure, extensive adoption of advanced pharmaceutical technologies, and supportive government policies targeting elderly care and chronic disease management. The region benefits from a mature market ecosystem that includes integrated care facilities, skilled long-term care providers, and a strong presence of pharmaceutical distributors. Regulatory frameworks such as Medicare and Medicaid in the United States provide financial incentives and coverage that bolster demand for long-term care pharmacy services. Moreover, major industry players like Omnicare (a CVS Health company), PharMerica, and BD Integrated Pharmacy Services contribute substantially by offering comprehensive medication management, adherence programs, and innovative pharmacy services that improve patient outcomes. Trade dynamics also favor North America through efficient supply chains and relationships with domestic and international drug manufacturers, ensuring reliable access to essential medicines.

Fastest-Growing Region: Asia Pacific

Meanwhile, the Asia Pacific region exhibits the fastest growth in the Long Term Care Pharmacy market, propelled by rapidly aging populations, increased healthcare expenditure, and expanding government initiatives to improve elderly care infrastructure. Countries such as Japan, China, and South Korea are investing heavily in healthcare modernization and policies that emphasize home-based and institutional long-term care services. The growing prevalence of chronic diseases and rising awareness around the importance of pharmaceutical care in long-term treatment plans further fuel market expansion. Additionally, the increasing penetration of multinational pharmacy service providers and local players, including Japan's Nichi-Iko Pharmaceutical and China's CSPC Pharmaceutical Group, helps scale distribution networks and customize services for regional needs. Trade liberalization and improvements in logistics also assist in reducing costs and enhancing drug availability, which accelerates uptake across urban and rural areas.

Long Term Care Pharmacy Market Outlook for Key Countries

United States

The United States' market remains highly advanced due to a comprehensive ecosystem comprising integrated long-term care facilities, sophisticated pharmacy service providers, and supportive government programs such as Medicare Part D that cover prescription medications. Omnicare and PharMerica dominate with their wide range of clinical services, including medication therapy management and telepharmacy, which enhance medication adherence and patient safety. Innovations in electronic health records integration and data analytics further improve service efficiency and regulatory compliance, consolidating the U.S. market's leading position globally.

Japan

Japan continues to lead the Asia Pacific market with its early adoption of long-term care insurance reforms and a national focus on elder care. The government's policies emphasize home care and institutional support, creating a fertile environment for long term care pharmacy services. Companies like Nichi-Iko Pharmaceutical and Santen Pharmaceutical play vital roles by supplying tailored medication and comprehensive pharmaceutical management solutions designed for Japan's aging population, supported by strong government subsidies and healthcare partnerships.

Germany

Germany's market is characterized by a robust healthcare system supplemented by statutory long-term care insurance that ensures broad access to pharmacy services for elderly and chronic patients. The country's well-developed home care and nursing facility networks require specialized pharmacy support, met by key players such as Celesio AG and Noweda. Germany's strong regulatory oversight and quality standards compel pharmacies to maintain high levels of service and safety, making the market both competitive and patient-focused.

China

China's rapidly expanding long-term care pharmacy market arises from significant healthcare reforms targeting aging demographics and chronic disease management. Government initiatives promoting elder care services and digital health integration catalyze growth. Major domestic pharmaceutical corporations like CSPC Pharmaceutical Group and Shanghai Pharmaceuticals are instrumental in expanding pharmacy networks and improving drug accessibility. The government's encouragement of private-public partnerships fosters innovation and wider service reach across urban and less developed regions.

United Kingdom

The United Kingdom's market benefits from the National Health Service (NHS) framework, which provides structured support for long-term care pharmaceuticals through community pharmacies and care homes. Key players including LloydsPharmacy and Well Pharmacy operate extensively within this framework, offering medication management programs tailored to elderly care. Additionally, the UK government's investment in digital health solutions and policy emphasis on integrated care models strengthen the role of long-term care pharmacies in improving medication adherence and clinical outcomes.

Market Report Scope

Long Term Care Pharmacy

Report Coverage

Details

Base Year

2024

Market Size in 2025:

USD 35.4 billion

Historical Data For:

2020 To 2023

Forecast Period:

2025 To 2032

Forecast Period 2025 To 2032 CAGR:

7.60%

2032 Value Projection:

USD 58.9 billion

Geographies covered:

North America: U.S., Canada
Latin America: Brazil, Argentina, Mexico, Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
Middle East: GCC Countries, Israel, Rest of Middle East
Africa: South Africa, North Africa, Central Africa

Segments covered:

By Service Type: Medication Dispensation , Clinical Pharmacy Services , Medication Therapy Management , Regulatory Compliance Services , Others
By End-User: Nursing Homes , Assisted Living Facilities , Home Health Care , Hospice Care , Others
By Drug Type: Oral Solids , Injectables , Topicals , IV Medications , Others

Companies covered:

PharMerica, CVS Health, Omnicare (a CVS Health company), Cardinal Health, Kindred Healthcare, Walgreens Boots Alliance, Omnicell Inc., Diplomat Pharmacy, Genoa Healthcare, AscellaHealth, Humana Pharmacy Solutions, Remedy Partners, Option Care Health, PruittHealth Pharmacy, Avella Specialty Pharmacy, BioScript Solutions

Growth Drivers:

Increasing prevalence of gastrointestinal disorders
Technological advancements in tube design and safety

Restraints & Challenges:

Risk of tube misplacement and complications
Discomfort and low patient compliance

Market Segmentation

Service Type Insights (Revenue, USD, 2020 - 2032)

  • Medication Dispensation
  • Clinical Pharmacy Services
  • Medication Therapy Management
  • Regulatory Compliance Services
  • Others

End-user Insights (Revenue, USD, 2020 - 2032)

  • Nursing Homes
  • Assisted Living Facilities
  • Home Health Care
  • Hospice Care
  • Others

Drug Type Insights (Revenue, USD, 2020 - 2032)

  • Oral Solids
  • Injectables
  • Topicals
  • IV Medications
  • Others

Regional Insights (Revenue, USD, 2020 - 2032)

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa

Key Players Insights

  • PharMerica
  • CVS Health
  • Omnicare (a CVS Health company)
  • Cardinal Health
  • Kindred Healthcare
  • Walgreens Boots Alliance
  • Omnicell Inc.
  • Diplomat Pharmacy
  • Genoa Healthcare
  • AscellaHealth
  • Humana Pharmacy Solutions
  • Remedy Partners
  • Option Care Health
  • PruittHealth Pharmacy
  • Avella Specialty Pharmacy
  • BioScript Solutions

Long Term Care Pharmacy Report - Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

  • Research Objectives
  • Assumptions
  • Abbreviations

2. MARKET PURVIEW

  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Long Term Care Pharmacy, By Service Type
  • Long Term Care Pharmacy, By End-User
  • Long Term Care Pharmacy, By Drug Type

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Long Term Care Pharmacy, By Service Type, 2025-2032, (USD)

  • Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
  • Medication Dispensation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Clinical Pharmacy Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Medication Therapy Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Regulatory Compliance Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)

5. Long Term Care Pharmacy, By End-User, 2025-2032, (USD)

  • Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
  • Nursing Homes
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Assisted Living Facilities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Home Health Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Hospice Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)

6. Long Term Care Pharmacy, By Drug Type, 2025-2032, (USD)

  • Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
  • Oral Solids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Injectables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Topicals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • IV Medications
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD)

7. Global Long Term Care Pharmacy, By Region, 2020 - 2032, Value (USD)

  • Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD)
  • Regional Trends
  • North America
  • Introduction
  • Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By Drug Type , 2020 - 2032, Value (USD)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By Drug Type , 2020 - 2032, Value (USD)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By Drug Type , 2020 - 2032, Value (USD)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By Drug Type , 2020 - 2032, Value (USD)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By Drug Type , 2020 - 2032, Value (USD)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, By Service Type , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By End-User , 2020 - 2032, Value (USD)
  • Market Size and Forecast, By Drug Type , 2020 - 2032, Value (USD)
  • South Africa
  • North Africa
  • Central Africa

8. COMPETITIVE LANDSCAPE

  • PharMerica
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • CVS Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Omnicare (a CVS Health company)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Cardinal Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Kindred Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Walgreens Boots Alliance
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Omnicell Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Diplomat Pharmacy
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Genoa Healthcare
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • AscellaHealth
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Humana Pharmacy Solutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Remedy Partners
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Option Care Health
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • PruittHealth Pharmacy
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Avella Specialty Pharmacy
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • BioScript Solutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. References and Research Methodology

  • References
  • Research Methodology
  • About us

*Browse 32 market data tables and 28 figures on 'Long Term Care Pharmacy' - Global forecast to 2032

Happy To Assist You

We are happy to help! Call or write to us

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides an industry forecast. The market was valued at US$ xxx million in 2025, and is expected to grow at a CAGR of xx% during the period 2025–2032.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Var Worldwide Market Reports Pvt Ltd, 402, Bremen Business Center, University Road, Pune-411007,India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By
paymenticon
Connect Us
© 2025 Worldwide Market Reports. All Rights Reserved